Recent development in the design of sialyltransferase inhibitors

Xiaofang Wang, Li He Zhang, Xin Shan Ye

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Sialylation at the non-reducing end of glycoconjugates is an important biological process in cellular recognitions, tumor metastases, and immune responses, which are mediated by a family of enzymes known as sialyltransferases. Inhibition of sialyltransferases may prove useful in elucidating the biological functions of sialylation and may have therapeutic applications. This review summarizes the recent development in this field with particular focus on the strategies used for the design of carbohydrate mimetics and the structure-activity relationships of substrate-based sialyltransferase inhibitors.

Original languageEnglish (US)
Pages (from-to)32-47
Number of pages16
JournalMedicinal Research Reviews
Volume23
Issue number1
DOIs
StatePublished - Jan 1 2003

Fingerprint

Sialyltransferases
Biological Phenomena
Glycoconjugates
Structure-Activity Relationship
Tumors
Carbohydrates
Neoplasm Metastasis
Substrates
Enzymes
Neoplasms
Therapeutics

Keywords

  • Carbohydrate mimetics
  • Inhibitor
  • Review
  • Sialyltransferase
  • Structure-activity relationship

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery

Cite this

Recent development in the design of sialyltransferase inhibitors. / Wang, Xiaofang; Zhang, Li He; Ye, Xin Shan.

In: Medicinal Research Reviews, Vol. 23, No. 1, 01.01.2003, p. 32-47.

Research output: Contribution to journalArticle

Wang, Xiaofang ; Zhang, Li He ; Ye, Xin Shan. / Recent development in the design of sialyltransferase inhibitors. In: Medicinal Research Reviews. 2003 ; Vol. 23, No. 1. pp. 32-47.
@article{78e53c7fcddd4d1985ce33b94d22cfac,
title = "Recent development in the design of sialyltransferase inhibitors",
abstract = "Sialylation at the non-reducing end of glycoconjugates is an important biological process in cellular recognitions, tumor metastases, and immune responses, which are mediated by a family of enzymes known as sialyltransferases. Inhibition of sialyltransferases may prove useful in elucidating the biological functions of sialylation and may have therapeutic applications. This review summarizes the recent development in this field with particular focus on the strategies used for the design of carbohydrate mimetics and the structure-activity relationships of substrate-based sialyltransferase inhibitors.",
keywords = "Carbohydrate mimetics, Inhibitor, Review, Sialyltransferase, Structure-activity relationship",
author = "Xiaofang Wang and Zhang, {Li He} and Ye, {Xin Shan}",
year = "2003",
month = "1",
day = "1",
doi = "10.1002/med.10030",
language = "English (US)",
volume = "23",
pages = "32--47",
journal = "Medicinal Research Reviews",
issn = "0198-6325",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Recent development in the design of sialyltransferase inhibitors

AU - Wang, Xiaofang

AU - Zhang, Li He

AU - Ye, Xin Shan

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Sialylation at the non-reducing end of glycoconjugates is an important biological process in cellular recognitions, tumor metastases, and immune responses, which are mediated by a family of enzymes known as sialyltransferases. Inhibition of sialyltransferases may prove useful in elucidating the biological functions of sialylation and may have therapeutic applications. This review summarizes the recent development in this field with particular focus on the strategies used for the design of carbohydrate mimetics and the structure-activity relationships of substrate-based sialyltransferase inhibitors.

AB - Sialylation at the non-reducing end of glycoconjugates is an important biological process in cellular recognitions, tumor metastases, and immune responses, which are mediated by a family of enzymes known as sialyltransferases. Inhibition of sialyltransferases may prove useful in elucidating the biological functions of sialylation and may have therapeutic applications. This review summarizes the recent development in this field with particular focus on the strategies used for the design of carbohydrate mimetics and the structure-activity relationships of substrate-based sialyltransferase inhibitors.

KW - Carbohydrate mimetics

KW - Inhibitor

KW - Review

KW - Sialyltransferase

KW - Structure-activity relationship

UR - http://www.scopus.com/inward/record.url?scp=0037216054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037216054&partnerID=8YFLogxK

U2 - 10.1002/med.10030

DO - 10.1002/med.10030

M3 - Article

VL - 23

SP - 32

EP - 47

JO - Medicinal Research Reviews

JF - Medicinal Research Reviews

SN - 0198-6325

IS - 1

ER -